Randomized controlled phase III trial of adjuvant chemoimmunotherapy with activated cytotoxic T cells and dendritic cells from regional lymph nodes of patients with lung cancer

Randomized controlled trial of adjuvant chemoimmunotherapy for lung cancer indicated a significant advantage in patients receiving immunotherapy. Herein we report the final results and immunological analysis with a median follow-up of 59.6 months. Patients with post-surgical lung cancer were randoml...

Descripción completa

Detalles Bibliográficos
Autores principales: Kimura, Hideki, Matsui, Yukiko, Ishikawa, Aki, Nakajima, Takahiro, Iizasa, Toshihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6097784/
https://www.ncbi.nlm.nih.gov/pubmed/29855695
http://dx.doi.org/10.1007/s00262-018-2180-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6097784/
https://www.ncbi.nlm.nih.gov/pubmed/29855695
http://dx.doi.org/10.1007/s00262-018-2180-6

Ejemplares similares